Antimicrobial peptide for bacterial infection imaging: first case reported in Brazil

• Published in: Einstein (Sao Paulo, Brazil) Brazil), 2023, Vol.21, p.eRC0621-eRC0621
• Main Authors: Nogueira, Solange Amorim, Barboza, Marycel Rosa Felisa Figols de, Bezerra, Rosemeire Pereira, Cabeza, Jorge Mejia, Dell'Aquila, Adriana Macedo, Santos, Durval do Carmo Barros, Yamaga, Lilian Yuri Itaya, Osawa, Akemi
• Format: Report
• Language: English
• ISSN: 2317-6385
• DOI: 10.31744/einstein_journal/2023RC0621

Molecular imaging markers can be used to differentiate between infection and aseptic inflammation, determine the severity of infection, and monitor treatment responses. One of these markers is ubiquicidin(29-41) (UBI), a cationic peptide fragment that binds to the bacterial membrane wall and is labeled with gallium-68 (68Ga), a positron emitter radioisotope. The use of UBI in positron emission tomography (PET)/computed tomography (CT) for improved detection of lesions has been receiving considerable attention recently. Herein, we report the first case of 68Ga-UBI PET/CT performed in Brazil. The patient was a 39-year-old woman referred for a scan to confirm a clinical suspicion of chronic osteomyelitis of her fractured left tibia. PET images revealed radiotracer uptake near the posterior contour of the tibial fracture focus and the fixation plate, in the soft tissue around the distal half of the tibia, and in the non-consolidated fracture of the left distal fibula. Surgery for local cleaning was performed, and culture of a specimen collected from the surgical site confirmed the presence of Staphylococcus aureus. In the present case, 68Ga-UBI PET/CT, a non-invasive imaging modality, identified the infection foci in vivo, indicating its potential for clinical use.